Questions about this study?
The HopeStage team will email you.
Active Not RecruitingNCT05805176
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
Device studyAges 18–55United States
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- Jacksonville and 4 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 15, 2023
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 194
- Sponsor
- Lumos Labs, Inc.
- Sponsor type
- Other organization
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT05805176
- Official title
Show the full official title
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Prospective, Multicenter, Open Label, Single Arm, Intervention Study to Assess Efficacy and Safety of an At-home, Game-based Digital Therapy for Treating Clinical Symptoms of Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)
Recruitment & locations
Not recruitingJacksonville · Lakeland · Rochester Hills
2 more locations
- Brentwood
- Berlin
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Lumos Labs, Inc.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me